NZ254102A - Receptor derivatives having binding sites for human rhinoviruses of the "small rhinovirus receptor group" preparation and use thereof - Google Patents

Receptor derivatives having binding sites for human rhinoviruses of the "small rhinovirus receptor group" preparation and use thereof

Info

Publication number
NZ254102A
NZ254102A NZ254102A NZ25410293A NZ254102A NZ 254102 A NZ254102 A NZ 254102A NZ 254102 A NZ254102 A NZ 254102A NZ 25410293 A NZ25410293 A NZ 25410293A NZ 254102 A NZ254102 A NZ 254102A
Authority
NZ
New Zealand
Prior art keywords
receptor
preparation
binding sites
derivatives
human rhinoviruses
Prior art date
Application number
NZ254102A
Other languages
English (en)
Inventor
Franz Hofer
Heinrich Kowalski
Martin Gruenberger
Herwig Machat
Manfred Huettinger
Donscho Kerjaschki
Ernst Kuechler
Dieter Blaas
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4222385A external-priority patent/DE4222385A1/de
Priority claimed from DE19924227892 external-priority patent/DE4227892A1/de
Priority claimed from DE19934305063 external-priority patent/DE4305063A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NZ254102A publication Critical patent/NZ254102A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
NZ254102A 1992-07-08 1993-07-05 Receptor derivatives having binding sites for human rhinoviruses of the "small rhinovirus receptor group" preparation and use thereof NZ254102A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4222385A DE4222385A1 (de) 1992-07-08 1992-07-08 Verfahren zur Isolierung von Inhibitoren des Rhinovirus-Rezeptors
DE19924227892 DE4227892A1 (de) 1992-08-22 1992-08-22 Derivate des Rezeptors der "kleinen Rhinovirus-Rezeptorgruppe" sowie die dafür codierenden DNA-Moleküle
DE19934305063 DE4305063A1 (de) 1993-02-19 1993-02-19 Rezeptorderivate

Publications (1)

Publication Number Publication Date
NZ254102A true NZ254102A (en) 1997-08-22

Family

ID=27203940

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ254102A NZ254102A (en) 1992-07-08 1993-07-05 Receptor derivatives having binding sites for human rhinoviruses of the "small rhinovirus receptor group" preparation and use thereof

Country Status (11)

Country Link
EP (1) EP0613498A1 (xx)
JP (1) JPH06510673A (xx)
CN (1) CN1082609A (xx)
AU (1) AU678978B2 (xx)
CA (1) CA2117099A1 (xx)
FI (1) FI941077A (xx)
HU (1) HUT68246A (xx)
IL (1) IL106287A0 (xx)
MX (1) MX9304074A (xx)
NZ (1) NZ254102A (xx)
WO (1) WO1994001553A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
GB9314951D0 (en) * 1993-07-17 1993-09-01 Prodrive Eng Ltd Gear change mechanism
US8598332B1 (en) 1998-04-08 2013-12-03 Bayer Cropscience N.V. Methods and means for obtaining modified phenotypes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745060A (en) * 1984-12-28 1988-05-17 Board Of Regents, The University Of Texas System Methods and compositions for the detection of Familial Hypercholesterolemia
DE3712678A1 (de) * 1987-04-14 1988-10-27 Boehringer Ingelheim Int Rezeptor der kleinen rhinovirus rezeptor gruppe
EP0358977A1 (en) * 1988-08-23 1990-03-21 The General Hospital Corporation Cloned nephritis antigen

Also Published As

Publication number Publication date
FI941077A0 (fi) 1994-03-08
WO1994001553A1 (de) 1994-01-20
HU9400675D0 (en) 1994-06-28
EP0613498A1 (de) 1994-09-07
HUT68246A (en) 1995-06-28
AU678978B2 (en) 1997-06-19
JPH06510673A (ja) 1994-12-01
CA2117099A1 (en) 1994-01-20
AU4564093A (en) 1994-01-31
CN1082609A (zh) 1994-02-23
MX9304074A (es) 1994-05-31
IL106287A0 (en) 1993-11-15
FI941077A (fi) 1994-03-08

Similar Documents

Publication Publication Date Title
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
IL116853A0 (en) Metallocene compounds their preparation and use
IL114018A0 (en) Genes for the synthesis of antipathogenic substances their preparation and their use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
GB2255503B (en) Improved use of ß2-bronchodilator drugs
OA09682A (en) Substituted benzimidazoles process for their preparation and their pharmaceutical use
EP0331620A3 (en) Agent for the treatment of parkinson's disease
AU1784992A (en) Subunit of the human interleukin-3 receptor
ZA904991B (en) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)-diazepin-6-ones and-thiones and their use for the treatment of aids
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
ZA929770B (en) Heterocyclic compounds and their preparation and use
IL105587A0 (en) Human metabotropic glutamate receptor and related dna compounds
AU4163793A (en) Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease
EG21121A (en) 13 Substituted milbemycin derivatives their preparation and use
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
NZ254102A (en) Receptor derivatives having binding sites for human rhinoviruses of the "small rhinovirus receptor group" preparation and use thereof
AP9801275A0 (en) Use of tricyclic 1,4-dihydro-1,4-dioxo-1H-naphthalene derivatives resulting novel compounds and therapeutical use thereof
AU9064191A (en) Use of angiotensin ii receptor antagonists in the treatment of atheroma
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL107726A0 (en) Pyrrole derivatives their preparation and their therapeutic use
GB2323357B (en) Derivatives of 7-deaza-2-deoxy-guanosine-5'-triphosphate, preparation and use thereof
AU1807592A (en) New combination preparation for treatment of parkinson's disease
NO921086L (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner